Novel Applications of MICA-Binding Fusion Molecules

Publication ID: 24-11857571_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Novel Applications of MICA-Binding Fusion Molecules,” Published Technical Disclosure No. 24-11857571_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857571_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,571.

Summary of the Inventive Concept

This inventive concept leverages the core technology of anti-MICA antigen binding fragments to address pressing issues in water quality, skin conditions, respiratory diseases, agriculture, and food safety, opening up new avenues for innovation and commercialization.

Background and Problem Solved

The original patent disclosed anti-MICA antigen binding fragments, fusion molecules, cells, and methods of using them, primarily focused on natural killer cells and cancer therapy. However, the patent's limitations in terms of applicability and scope hindered its potential in other fields. This inventive concept solves this problem by applying the core technology to entirely new industries and use cases, capitalizing on the versatility and adaptability of MICA-binding fusion molecules.

Detailed Description of the Inventive Concept

The new claims encompass a system for monitoring and controlling water quality, a method for reducing inflammation in skin conditions, a device for diagnosing and treating respiratory diseases, a method for enhancing crop yields, and a system for detecting and preventing foodborne illnesses. Each of these applications leverages the MICA-binding fusion molecule's ability to detect and neutralize specific targets, providing innovative solutions to pressing problems in their respective fields.

Novelty and Inventive Step

The novelty of this inventive concept lies in its application of the anti-MICA antigen binding fragments to entirely new industries and use cases, demonstrating an inventive step beyond the original patent's scope. The new claims introduce unexpected and non-obvious uses for the core technology, expanding its potential for commercialization and impact.

Alternative Embodiments and Variations

Alternative embodiments of this inventive concept could include the development of MICA-binding fusion molecules with tailored specificity for different applications, the integration of these molecules with existing technologies, or the exploration of new delivery methods and formulations. Variations could involve adapting the core technology to address related problems within each industry, such as using MICA-binding fusion molecules to detect and treat other waterborne pathogens or to monitor and control air quality.

Potential Commercial Applications and Market

The commercial potential of this inventive concept is vast, with applications in water quality management, skin care, respiratory disease diagnosis and treatment, agriculture, and food safety. The target industries include water treatment, pharmaceuticals, medical devices, agriculture, and food processing, with potential partnerships and collaborations with companies, research institutions, and government agencies.

Original Patent Information

Patent NumberUS 11,857,571
TitleAnti-mica antigen binding fragments, fusion molecules, cells which express and methods of using
Assignee(s)The Trustees of Dartmouth College